Page of

Discovery of the Decade Cont.

USA Discovery of the Decade in Pharma – Novartis for Gleevec 

The first time in cancer treatment that scientists were able to identify a chromosomal abnormality and then develop a drug to target that specific protein.

Previous Next

USA Discovery of the Decade in Biotech – BMS for Yervoy 

First FDA-approved drug for the treatment of metastatic melanoma.

Next Previous